RenaissanceRe Holdings Ltd.

  • Market Cap: Small Cap
  • Industry: Insurance
  • ISIN: BMG7496G1033
USD
273.37
1.67 (0.61%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About RenaissanceRe Holdings Ltd. stock-summary
stock-summary
RenaissanceRe Holdings Ltd.
Insurance
RenaissanceRe Holdings Ltd. provides reinsurance and insurance coverages and related services to a range of customers. The Company's products include property, casualty and specialty reinsurance and certain insurance products principally distributed through intermediaries. Its segments include Property; Casualty and Specialty, and Other category. The Property segment consisted of catastrophe and other property reinsurance and insurance written on behalf of its operating subsidiaries and certain joint ventures managed by its ventures unit. The Casualty and Specialty segment consisted of casualty and specialty reinsurance and insurance written on behalf of its operating subsidiaries and certain joint ventures managed by its ventures unit. Its Other category includes its strategic investments, investments unit, corporate expenses, capital servicing. The Casualty and Specialty segment offers certain casualty insurance products through RenaissanceRe Syndicate 1458 (Syndicate 1458).
Company Coordinates stock-summary
Company Details
Renaissance House, 12 Crow Lane , PEMBROKE None : HM 19
stock-summary
Tel: 1 441 29545131 441 2954513
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 113 Schemes (45.89%)

Foreign Institutions

Held by 203 Foreign Institutions (24.49%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. James Gibbons
Non-Executive Independent Chairman of the Board
Mr. Kevin O'Donnell
President, Chief Executive Officer, Director
Mr. David Bushnell
Independent Director
Mr. Brian Gray
Independent Director
Ms. Jean Hamilton
Independent Director
Mr. Duncan Hennes
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2025)
Net Profit:
1,317 Million
stock-summary
Industry

Insurance

stock-summary
Market cap

USD 12,647 Million (Small Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.63%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

14.81%

stock-summary
Price to Book

1.10